[{"orgOrder":0,"company":"Russian Academy of Medical Sciences","sponsor":"Dr. Falk Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"RUSSIA","productType":"Plant Extract\/Herbal","year":"2013","type":"Inapplicable","leadProduct":"Psyllium","moa":"Homeostasis","graph1":"Gastroenterology","graph2":"Phase IV","graph3":"Russian Academy of Medical Sciences","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Russian Academy of Medical Sciences \/ Dr. Falk Pharma","highestDevelopmentStatusID":"11","companyTruncated":"Russian Academy of Medical Sciences \/ Dr. Falk Pharma"},{"orgOrder":0,"company":"VA Greater Los Angeles Healthcare System","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2017","type":"Inapplicable","leadProduct":"Psyllium","moa":"Homeostasis","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase IV","graph3":"VA Greater Los Angeles Healthcare System","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"VA Greater Los Angeles Healthcare System \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"VA Greater Los Angeles Healthcare System \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Psyllium","moa":"Homeostasis","graph1":"Endocrinology","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Duke University","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Psyllium","moa":"Homeostasis","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROCTER AND GAMBLE \/ Duke University","highestDevelopmentStatusID":"1","companyTruncated":"PROCTER AND GAMBLE \/ Duke University"},{"orgOrder":0,"company":"Amsterdam UMC, VUmc","sponsor":"Teva Pharmaceutical Industries","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"NETHERLANDS","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"Psyllium","moa":"quaternary ammonium derivatives","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Amsterdam UMC, VUmc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Amsterdam UMC, VUmc \/ Teva Pharmaceutical Industries","highestDevelopmentStatusID":"1","companyTruncated":"Amsterdam UMC, VUmc \/ Teva Pharmaceutical Industries"}]

Find Clinical Drug Pipeline Developments & Deals for Psyllium

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          VA Greater Los Angeles Healthcare System

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          VA Greater Los Angeles Healthcare System

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Psyllium is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hyperlipidemias.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          December 12, 2017

                          Lead Product(s) : Psyllium

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Amsterdam UMC, VUmc

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Amsterdam UMC, VUmc

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Psyllium Husk is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          August 16, 2016

                          Lead Product(s) : Psyllium

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Teva Pharmaceutical Industries

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Russian Academy of Medical Sciences

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Russian Academy of Medical Sciences

                          Country arrow
                          OTS 2025
                          Not Confirmed

                          Details : Mucofalk (Psyllium) is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gastroesophageal Reflux.

                          Product Name : Mucofalk

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          June 20, 2013

                          Lead Product(s) : Psyllium

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Phase IV

                          Sponsor : Dr. Falk Pharma

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Psyllium is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Mellitus, Type 2.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          April 20, 2012

                          Lead Product(s) : Psyllium

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Psyllium is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypoglycemia.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 09, 2012

                          Lead Product(s) : Psyllium

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Sponsor : Duke University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank